Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Biogen Beats Second-Quarter Expectations

TheMotleyFool

0 0

Biogen Beats Second-Quarter Expectations

Shares of Biogen (NASDAQ: BIIB) hardly moved following the release of second-quarter earnings results that beat Wall Street's expectations on the top and bottom lines.

Revenue rose 1.7% year over year to $3.7 billion, exceeding the average analyst estimate by $240 million. Adjusted earnings rose 12% to $10.26 per share, $2.25 per share higher than expected.

Image source: Getty Images.

Source Fool.com

Like: 0

BIIB

Share